Marine biological toxin detection kit, marine biological toxin detection method and inhibitor screening method

By monitoring cell indices using RTCA technology, a detection method for Na+ channel-inhibiting marine biotoxins was established, solving the problem of insufficient sensitivity in existing detection methods and achieving highly sensitive and convenient toxin screening and identification.

CN119020449APending Publication Date: 2024-11-26ACADEMY OF MILITARY MEDICAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411270658.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing detection methods are insufficient to achieve highly sensitive, convenient, and effect-oriented high-throughput screening and semi-quantitative detection of Na+ channel-inhibiting marine biotoxins.

Method used

Using real-time label-free cell analysis (RTCA) technology, cell indices of target cells are monitored through a microelectronic cell sensor chip. By combining the contact between target cells and biotoxins and substances that activate Na+ channels, a standard curve is established and the toxin concentration is calculated. A kit for detecting Na+ channel-inhibiting biotoxins and a method for screening biotoxin inhibitors are developed.

Benefits of technology

It enables rapid screening and accurate identification of Na+ channel-inhibiting marine biotoxins, with a detection limit of 0.1 ng, providing a highly sensitive and convenient detection method and supporting the application of on-site rapid testing systems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020449A_ABST
    Figure CN119020449A_ABST
Patent Text Reader

Abstract

The invention relates to a marine organism toxin detection kit, a detection method and an inhibitor screening method, in particular to a method for quantitatively detecting biotoxins in a sample, which comprises the following steps: (1) respectively contacting standard substances of the biotoxins with different working concentrations and substances capable of activating Na < + > channels with target cells, monitoring the cell index of the target cell by using RTCA (Real-time Non-Label Cell Analysis), carrying out normalization processing on the cell index, calculating the cell activity according to the normalized cell index of the test group and the blank control group, and determining the function relationship between the biotoxin concentration and the cell activity of the target cell; and (2) contacting the sample and a substance capable of activating the Na < + > channel with target cells, monitoring the cell indexes of the target cells by using RTCA, normalizing the cell indexes, and calculating the cell activity according to the normalized cell indexes of a test group and a blank control group, and calculating the concentration of the biotoxin in the sample according to the functional relationship between the concentration of the biotoxin and the cell activity of the target cell determined in the step (1). The method can realize sensitive and specific detection of the ion channel inhibition type biotoxin.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotoxin detection, and in particular to a marine biotoxin detection kit, a detection method, and a marine biotoxin inhibitor screening method. Background Art

[0002] Marine biotoxins are mainly secondary metabolites produced by specific types of bacteria, harmful algae, etc. They have special chemical structures and extremely high biological toxicity. They can accumulate in shellfish, finfish, etc. through the food chain and cause poisoning or even death to other animals and humans. Most marine biotoxins act on ion channels and can be divided into Na+, N+, and N+ according to their toxic effects. + Channel-acting marine toxins, K + Channel-acting marine toxins and Ca 2+ Channel-acting marine toxins. Among them, Na + Channel-inhibiting marine toxins include paralytic shellfish poison (PSP) and tetrodotoxin (TTX), which are the most harmful marine biotoxins to human and animal life. + The detection of channel-inhibiting marine toxins is of great significance.

[0003] Currently used to detect Na + Methods for detecting channel-inhibiting marine biotoxins include in vivo bioassays in mice, physicochemical analysis, in vitro cytotoxicity assays, and immunological assays. However, there is still no method that can simultaneously perform more sensitive, convenient, and effect-oriented flux screening and semi-quantitative detection of Na + Methods for channel inhibition of marine toxins.

[0004] Real-time label-free cell analysis (RTCA) is a method based on cell biosensing and a new method for in vitro cell analysis. It uses a special process to integrate a microelectronic cell sensor chip into the bottom of a cell detection plate to build a cell impedance detection sensor system that can track changes in cell morphology, proliferation and differentiation in real time, dynamically and quantitatively. RTCA has been widely used in research on microbiology, plant metabolites, environmental toxicity, cell function and new potential anticancer drugs, but is currently less used in the detection of biological toxins. Summary of the invention

[0005] The present invention aims to establish a RTCA method for detecting ion channel-acting biological toxins and develop a RTCA method for detecting Na + A kit for channel-inhibiting biotoxins and a method for screening biotoxin inhibitors.

[0006] In summary, focusing on the common toxicity mechanisms caused by poisons after exposure, we develop detection methods for rapid screening and accurate identification of ion channel-acting poisons and toxins, to solve the current difficulties in throughput screening of such substances and in real-time assessment of their toxic effects, and to establish scientific and reliable biosensing methods that can complement and support the existing on-site rapid detection system.

[0007] To achieve the above purpose, the specific technical solution of the present invention is as follows:

[0008] In one aspect, the present invention provides a method for quantitatively detecting biotoxins in a sample, comprising:

[0009] (1) respectively mixing the standard of the biotoxin with different working concentrations and the + The substance in the channel contacts the target cells, the cell index of the target cells is monitored by RTCA, the cell index is normalized, the cell viability is calculated according to the normalized cell index of the test group and the blank control group, and the functional relationship between the concentration of the biotoxin and the cell viability of the target cells is determined;

[0010] (2) mixing the sample with a + The material in the channel contacts the target cells, the cell index of the target cells is monitored by RTCA, the cell index is normalized, the cell viability is calculated based on the normalized cell index of the test group and the blank control group, and the concentration of the biotoxin in the sample is calculated based on the functional relationship between the concentration of the biotoxin determined in step (1) and the cell viability of the target cells.

[0011] As known in the art, RTCA integrates microelectronics, cell biology and molecular biology. The core of the technology is a microelectronic biosensor chip, which is integrated into the wells of the cell culture plate, so that the cell function analyzer can detect the activity of living cells in real time without any labeling. The real-time label-free cell function analyzer can simply and reliably detect the parameters of the cell, such as adhesion, extension, growth, death, and even specific morphological changes. In RTCA, the state of the cell can be measured by the cell index (Cell Index). Living cells interact with the microelectrodes in the holes of the detection plate to produce changes in electrical impedance, and the system converts these signals into specific parameters, namely the cell index. In some embodiments, the cell index is normalized to obtain a normalized cell index (NCI). In some embodiments, the state of the cells treated with a series of concentrations of toxin standard products is continuously monitored over a period of time (e.g., 12h-72h, e.g., 24h-72h, 48h-72h), and a normalized cell index curve is drawn. The maximum value of the normalized cell index of the toxin standard at each concentration is selected and divided by the normalized cell index value of the blank control group at the same time to obtain the cell viability value, and the cell viability and the concentration of the toxin standard are linearly fitted to obtain the standard working curve of the toxin (i.e., the functional relationship between the concentration of the biological toxin and the cell viability of the target cells).

[0012] In some embodiments, the sample contains or is suspected of containing the biotoxin.

[0013] In some embodiments, the sample is from a marine organism, such as seaweed, shellfish, or fish, such as filter-feeding shellfish (oysters, clams, scallops, or mussels).

[0014] In some embodiments, the biotoxin acts on an ion channel, such as Na + Channel, K + Channels or Ca 2+ channel, preferably acting on Na + aisle.

[0015] In some embodiments, the biotoxin is a marine biotoxin, such as paralytic shellfish poisoning or tetrodotoxin.

[0016] In some embodiments, the biotoxin is selected from polypeptide toxins (e.g., conotoxins (e.g., μ-conotoxin GⅢA)); alkaloid toxins (e.g., saxitoxin (STX), neoSxitoxin (neoSTX), gonyatoxin (GTX, e.g., GTX1, GTX4), tetrodotoxin (TTX)); polyether toxins (e.g., ciguatoxin (CTX), breve toxin).

[0017] In some embodiments, the + The channel substances were used to control the cell viability at 25%-50%.

[0018] In some embodiments, the + The substance of the channel is selected from ouabain and / or rerudin.

[0019] In some embodiments, the concentration of ouabain is 300-500 μM (e.g., 300 μM, 350 μM, 400 μM, 450 μM, 500 μM); and / or the concentration of verrudin is 30-50 μM (e.g., 30 μM, 35 μM, 40 μM, 45 μM, 50 μM).

[0020] In some embodiments, the steps (1) and (2) are capable of activating Na + The substance of the channel is the same, and further preferably, the substance capable of activating Na + The concentration of the substances in the channels is the same.

[0021] In some embodiments, the concentration of the target cells is 1×10 4 / mL~5×10 5 Pieces / mL, for example 1×10 5 / mL~3×10 5 Pieces / mL.

[0022] In some embodiments, the concentration of the target cells is 1×10 3 pcs / hole~5×10 4 Pieces / hole, for example 1×10 4 pcs / hole~3×10 4 Pieces / hole.

[0023] In some embodiments, the target cell is a Neuro-2a cell.

[0024] In some embodiments, RTCA is used for monitoring for 12 h-72 h, such as 24 h-72 h, 48 h-72 h.

[0025] In some embodiments, the method has a detection limit of 0.1 ng for STX.

[0026] In some embodiments, the method has a detection limit of 0.1 ng for neoSTX.

[0027] In some embodiments, the method has a detection limit of 0.1 ng for GTX, such as GTX1 and GTX4.

[0028] In some embodiments, the detection limit of the method for TTX is 0.1 ng. In some embodiments, the present invention provides a method for detecting marine toxins based on ion channel effect guidance and RTCA, comprising:

[0029] 1. Prepare the standard curve working solution

[0030] Select the STX standard solution and dilute it into a series of working solutions in serum-free 1640 medium;

[0031] 2. Prepare Veratridine and Ouabain working solution

[0032] Veratridine and Ouabain, two substances that can cause intracellular sodium ion overload, were selected and diluted with serum-free 1640 medium to prepare Veratridine and Ouabain working solutions;

[0033] 3. Prepare standard curve samples

[0034] The STX working solution, Veratridine working solution and Ouabain working solution were mixed to prepare the standard curve samples, wherein the concentration of Vertrdine was 50 μM and the concentration of Ouabain was 500 μM;

[0035] 4. RTCA test with standard working solution

[0036] 1. Instrument baseline detection

[0037] Add 50 μL of 1640 complete medium to each well for baseline detection;

[0038] 2. Cell plating

[0039] Take a bottle of Neuro-2a cells in the logarithmic growth phase, wash them twice with pre-cooled 1× PBS solution, digest the cells with trypsin solution, and resuspend them to adjust the cell density to 3×10 5 / mL, add E-plate 16 at 100μL per well;

[0040] 3. Monitoring of cell adhesion and spreading process

[0041] (IV) Real-time monitoring after cell administration

[0042] (V) Drawing a standard curve

[0043] The cell index (CI) curve after the test is normalized, and the NCI value with the largest difference in the normalized cell index (NCI) curve is selected and divided by the NCI value of the untreated group at the same time to obtain the cell viability value. The cell viability and the corresponding concentration are nonlinearly fitted to obtain the STX standard curve; the cell viability value of the sample to be tested is inserted into the standard curve to obtain the toxin content in the sample to be tested.

[0044] 5. Different Na + Detection of channel-inhibiting biotoxins

[0045] Standard solution dilutions of neoSTX, GTX1&4, and TTX were prepared in serum-free 1640 medium with the same concentration gradient and detected by RTCA.

[0046] In another aspect, the present invention provides a biotoxin detection kit, comprising target cells, a biotoxin standard and a reagent capable of activating Na + Channel material.

[0047] In some embodiments, the biotoxin acts on an ion channel, such as Na + Channel, K + Channels or Ca 2+ channel, preferably acting on Na + aisle.

[0048] In some embodiments, the biotoxin is a marine biotoxin, such as paralytic shellfish poisoning or tetrodotoxin.

[0049] In some embodiments, the biotoxin is selected from polypeptide toxins (e.g., tetrodotoxin (TTX), conotoxins (e.g., μ-conotoxin)); alkaloid toxins (e.g., saxitoxin (STX), neoSxitoxin (neoSTX), Gonadotoxin (GTX, e.g., GTX1, GTX4), sea anemone toxin); polyether toxins (e.g., ciguatoxin (CTX), breve toxin).

[0050] In some embodiments, the target cell is a Neuro-2a cell.

[0051] In some embodiments, the + The substance of the channel is selected from ouabain and / or rerudin.

[0052] In some embodiments, the concentration of ouabain is 300-500 μM (e.g., 300 μM, 350 μM, 400 μM, 450 μM, 500 μM); and / or the concentration of verrudin is 30-50 μM (e.g., 30 μM, 35 μM, 40 μM, 45 μM, 50 μM).

[0053] In some embodiments, the kit is used for RTCA analysis.

[0054] In some embodiments, the kit is used to detect a biotoxin in a sample.

[0055] In some embodiments, the sample contains or is suspected of containing the biotoxin.

[0056] In some embodiments, the sample is from a marine organism, such as seaweed, shellfish, or fish, such as filter-feeding shellfish (oysters, clams, scallops, or mussels).

[0057] In another aspect, the present invention provides a method for screening a biotoxin inhibitor, comprising:

[0058] (1) the biotoxin, the candidate agent and the + A mixed solution of the substances in the channel is added to a culture medium containing target cells, and monitored by RTCA to obtain a cell index curve of the target cells;

[0059] (2) using the culture medium without the addition of the biotoxin and the candidate agent as a control to obtain a cell index curve of the control group;

[0060] (3) The cell index was normalized to obtain the normalized cell index value, and the cell viability was calculated;

[0061] (4) Comparing the cell viability of the test group and the control group, the closer the two are, the stronger the activity of the candidate agent in inhibiting the biological toxin.

[0062] In some embodiments, the biotoxin acts on an ion channel, such as Na + Channel, K + Channels or Ca 2+ channel, preferably acting on Na + aisle.

[0063] In some embodiments, the biotoxin is a marine biotoxin, such as paralytic shellfish poisoning or tetrodotoxin.

[0064] In some embodiments, the biotoxin is selected from polypeptide toxins (e.g., tetrodotoxin (TTX), conotoxins (e.g., μ-conotoxin)); alkaloid toxins (e.g., saxitoxin (STX), neoSxitoxin (neoSTX), Gonadotoxin (GTX, e.g., GTX1, GTX4), sea anemone toxin); polyether toxins (e.g., ciguatoxin (CTX), breve toxin).

[0065] In some embodiments, the final concentration of the biotoxin in step (1) is 0.1 ng / mL-1 μg / mL, such as 50 ng / mL-500 ng / mL, 100 ng / mL-200 ng / mL.

[0066] In some embodiments, the + The substance of the channel is selected from ouabain and / or rerudin.

[0067] In some embodiments, the final concentration of ouabain in step (1) is 300-500 μM (e.g., 300 μM, 350 μM, 400 μM, 450 μM, 500 μM); and / or the concentration of verrucidine is 30-50 μM (e.g., 30 μM, 35 μM, 40 μM, 45 μM, 50 μM).

[0068] In some embodiments, the concentration of the target cells is 1×10 4 / mL~5×10 5 Pieces / mL, for example 1×10 5 / mL~3×10 5 Pieces / mL.

[0069] In some embodiments, the concentration of the target cells is 1×10 3 pcs / hole~5×10 4 Pieces / hole, for example 1×10 4 pcs / hole~3×10 4 Pieces / hole.

[0070] In some embodiments, the target cell is a Neuro-2a cell.

[0071] In some embodiments, the final concentration of the candidate agent is 50 nM-500 nM, such as 100 nM-200 nM.

[0072] In some embodiments, in the method described, RTCA is used for monitoring for 12h-72h, such as 24h-72h, 48h-72h. BRIEF DESCRIPTION OF THE DRAWINGS

[0073] The drawings herein are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0074] Figure 1 : Results of determining the optimal cell number using CCK-8 method.

[0075] Figure 2 :(A) The effect of Veratridine alone on cells; (B) The effect of Ouabain alone on cells.

[0076] Figure 3 :The results of the combined effects of Veratridine and Ouabain on cells.

[0077] Figure 4 :(A) Antagonism experiment between STX and 30μM Veratridine and 300μM Ouabain; (B) Antagonism experiment between STX and 50μM Veratridine and 500μM Ouabain.

[0078] Figure 5 : Results of determining the optimal cell number using the RTCA method.

[0079] Figure 6 : Results of STX detection by RTCA method: (A) Normalized cell index graph; (B) Relative cell viability bar graph; (C) Standard curve graph.

[0080] Figure 7 : Results of RTCA method detection of neoSTX: (A) Normalized cell index graph; (B) Relative cell viability bar graph; (C) Standard curve graph.

[0081] Figure 8 : RTCA method detection of GTX1&4 results: (A) Normalized cell index graph; (B) Relative cell viability bar graph; (C) Standard curve graph.

[0082] Fig. 9 : Results of TTX detection by RTCA method: (A) Normalized cell index graph; (B) Relative cell viability bar graph; (C) Standard curve graph.

[0083] Fig.10 :(A) The results of cell viability changes after STX combined with M-30f, STX-41, STX-apt1, and STX-apt2; (B) The results of cell viability changes after TTX combined with DA-01, TTX-27, and TTX-07.

[0084] Fig.11:STX standard curve establishment and real sample testing: (A) STX standardized cell index graph; (B) STX relative cell viability bar graph; (C) standard curve graph; (D) real sample standardized cell index graph; (E) real sample relative cell viability bar graph. DETAILED DESCRIPTION

[0085] Embodiment 1, Na + Establishment of RTCA detection method for channel-acting biotoxins

[0086] 1. Reagents and Materials

[0087] Saxitoxin (STX) and Gonyautoxin 1&4 (GTX 1&4) were purchased from Tianjin Alta Technology Co., Ltd.; Tetrodotoxin (TTX) was purchased from Beijing Dingfang Biotechnology Co., Ltd.; μ-Conotoxin GⅢA (μ-CNTX GⅢA) was purchased from Beijing Locust Biotechnology Co., Ltd.; Ouabain and Veratridine were purchased from Selleck Biotechnology Co., Ltd., USA. Mouse brain neuroma cells (Neuro-2a) were from the laboratory. 1640 culture medium, fetal bovine serum (FBS), and 0.25% trypsin (containing 0.02% ethylenediaminetetraacetic acid (EDTA)) were purchased from Gibco, USA; penicillin-streptomycin mixed solution was purchased from Gibco, USA. Cell culture flasks and 96-well plates were purchased from Corning, USA; E-plate 16 was purchased from Agilent Technologies, Inc. Cell counting chamber was purchased from Shanghai Qiujing Biochemical Reagent Instrument Co., Ltd.; liquid nitrogen and carbon dioxide were purchased from Beijing Huanyu Jinghui Jingcheng Gas Technology Co., Ltd.

[0088] 2. Main instruments and equipment

[0089] Table 1 Main instruments and equipment

[0090]

[0091] 3. Experimental Methods

[0092] (1) Solution preparation

[0093] Using DMSO as solvent, prepare 1mM ouabain and 100μM Veratridine standard solutions and store at -20°C. Dilute the stock solution with serum-free medium to obtain 100μM, 300μM, 500μM, 1000μM Ouabain solutions and 10μM, 30μM, 50μM, 100μM Veratridine solutions, and mix the diluted Ouabain and Veratridine solutions to obtain the OV working solution.

[0094] The saxitoxin (STX) standard solution is an aqueous solution with a concentration of 22.332 μg / mL, stored at 4° C. The stock solution was diluted stepwise with serum-free 1640 medium to obtain standard working solutions with concentrations of 0.03 ng / mL, 0.1 ng / mL, 0.3 ng / mL, 1 ng / mL, 10 ng / mL, and 100 ng / mL.

[0095] The neo-Saxitoxin (neoSTX) standard solution is an aqueous solution with a concentration of 10.25 μg / mL, stored at 4° C. The stock solution was diluted stepwise with serum-free medium to obtain standard working solutions with concentrations of 0.03 ng / mL, 0.1 ng / mL, 0.3 ng / mL, 1 ng / mL, 10 ng / mL, and 100 ng / mL.

[0096] The Gonyautoxin 1&4 (GTX1&4) standard solution is an aqueous solution with a concentration of 15.43 μg / mL and is stored at 4° C. The stock solution is diluted stepwise with serum-free culture medium to obtain standard working solutions with concentrations of 0.03 ng / mL, 0.1 ng / mL, 0.3 ng / mL, 1 ng / mL, 10 ng / mL, and 100 ng / mL.

[0097] A 1% acetic acid aqueous solution was used as solvent to prepare a 1 mg / mL tetrodotoxin (TTX) standard solution, which was stored at -20°C after aliquoting. The stock solution was diluted in serum-free medium to obtain standard working solutions with concentrations of 0.03 ng / mL, 0.1 ng / mL, 1 ng / mL, 10 ng / mL, 100 ng / mL, and 300 ng / mL.

[0098] Using DMSO as solvent, prepare μ-Conotoxin GⅢA (μ-CNTXGⅢA) standard solution with a concentration of 1 mg / mL, store at -20°C after aliquoting. Dilute the stock solution step by step with serum-free medium to obtain standard working solutions with concentrations of 0.03 ng / mL, 0.1 ng / mL, 1 ng / mL, 10 ng / mL, 100 ng / mL, and 300 ng / mL.

[0099] (2) CCK-8 method condition optimization

[0100] 1) Cultivation of Neuro-2a cells: Neuro-2a cells frozen in liquid nitrogen were taken out, and the cryopreservation solution was quickly thawed in a 37°C water bath. The cell suspension was transferred to 3 mL of 1640 medium containing 10% FBS and 1% double antibody (10 mg / mL streptomycin and 10000 U / mL penicillin), centrifuged at 500 rcf for 5 min, the supernatant was discarded, 4 mL of culture medium was added to the lower layer of cells to resuspend the cells, and then transferred to a T-25 cell culture flask. After observing the cell morphology under a microscope, the cells were cultured in a cell culture incubator (37°C, 5% CO2) and passaged every other day. The passaging procedure is to take cells in the logarithmic growth phase, discard the culture medium, rinse the cells twice with 1 mL of PBS solution, absorb 1 mL of cell digestion solution (0.25% trypsin, containing 0.02% EDTA) into the cell culture bottle to infiltrate the cells at the bottom, put it into the incubator for digestion for 2 minutes, observe under the microscope that the cells have obvious gaps and are basically round, tap and shake the bottom of the culture bottle to suspend the cells, add 3 mL of 1640 culture medium to terminate the digestion process, transfer the digested cells to a centrifuge tube, centrifuge at 500 rcf for 5 minutes, discard the supernatant, add 4 mL of complete culture medium to resuspend the cells, transfer them to a new cell culture bottle according to the appropriate ratio, and put them into the incubator for culture for use.

[0101] 2) Determination of the optimal cell number: Take out the cells in the logarithmic growth phase, obtain suspended cells according to step 1), count them with a cell counting plate, dilute the cell suspension to different densities, and seed a 96-well plate at 100 μL / well, with 3 replicates for each density. Let it stand for 20 minutes. After the cells sink to the bottom, place them in a cell culture incubator (37°C, 5% CO2) for culture. After 24 hours, take out the 96-well plate, add 10 μL CCK-8 dye to each well, place it in an incubator for incubation for 1-2 hours, and take it out to detect OD using an enzyme reader. 450 .

[0102] Results Figure 1 , the OD value gradually increased when the number of cells per well ranged from 1000 to 30000. When the number of cells per well exceeded 30000, the OD value began to decrease, indicating that the cells grew best when the number of cells per well was 30000.

[0103] 3) Investigation of Veratridine and Ouabain alone or in combination and concentration optimization:

[0104] Acts on Na + When biological toxins that activate Na channels are exposed to cells alone, they cause little damage to the cells. + In order to make Na + Channel inhibitor biotoxins have enough room to rescue cells, but at the same time, excessive cell damage should be avoided, which would result in low rescue efficiency. Therefore, cell viability should be controlled at 25%-50%. Veratridine is a Na + Channel agonists can make Na + Increased inflow. Ouabain is Na + -K + -ATPase inhibitors, which can reduce Na + The study investigated the effect of single Veratridine or Ouabain on cell viability, and then investigated the changes in cell viability after combined Veratridine and Ouabain poisoning.

[0105] Take out the cells in the logarithmic growth phase and obtain suspended cells according to step 1). After counting with a cell counting plate, adjust the cell suspension density to 3×10 5 cell / mL, seed the 96-well plate at 100μL / well, let it stand for 20min, wait for the cells to sink to the bottom, and then place it in a cell culture incubator. After 24h, take out the 96-well plate, discard the old culture medium, add different concentrations of Ouabain, Veratridine, and serum-free culture medium solutions mixed with Ouabain and Veratridine to the cells, and infect them for 24h. After the infection, take out the 96-well plate, wash the cells twice with PBS buffer, add 100μL 10% CCK-8 serum-free culture medium solution to each well of the cells, incubate in an incubator for 1-2h, and take out to detect OD with an enzyme marker 450 .

[0106] The results are as follows Figure 2 and Figure 3 shown. Figure 2 It was shown that when the concentration of Veratridine was 30 μM, the concentration of Ouabain was 300 μM or the concentration of Veratridine was 50 μM, the concentration of Ouabain was 500 μM, the cell viability after the action best met the condition requirements.

[0107] 4) CCK-8 method for detecting STX:

[0108] To keep the concentrations of Veratridine and Ouabain fixed, the changes in cell viability after the addition of STX were investigated.

[0109] Take out the cells in the logarithmic growth phase and obtain suspended cells according to step 1). After counting with a cell counting plate, adjust the cell suspension density to 3×10 5 cell / mL, seed 96-well plates at 100μL / well, seed 2 plates, let stand for 20min, wait for the cells to sink to the bottom, place in a cell culture incubator, take out the 96-well plates after 24h, discard the old culture medium, add different concentrations of STX mixed with 30μM Veratridine and 300μM Ouabain serum-free culture medium solution, different concentrations of STX mixed with 50μM Veratridine and 500μM Ouabain serum-free culture medium solution to the cells in the 2 plates, and infect for 24h. After the infection, take out the 96-well plates, wash the cells twice with PBS buffer, add 100μL 10% CCK-8 serum-free culture medium solution to each well of the cells, incubate in an incubator for 1-2h, take out and detect OD with an enzyme marker 450 .

[0110] The results are as follows Figure 4 As shown, when the concentration of Veratridine is 50 μM and the concentration of Ouabain is 500 μM, the two act on cells together with different concentrations of STX, and the cell viability gradually increases. This condition is better than the administration condition of Veratridine concentration of 30 μM and Ouabain concentration of 300 μM.

[0111] (3) RTCA method for detecting Na + Marine biotoxins with channel inhibition mechanisms

[0112] 1) Determination of the optimal number of cells to be plated and the optimal administration time: Take out the cells in the logarithmic growth phase, and obtain suspended cells according to the above-mentioned "CCK-8 method condition optimization" step 1). After counting with a cell counting plate, the cell suspension is gradiently diluted to different densities and inoculated on E-plate 16 at 100 μL / well, with 2 replicate wells for each density. Let it stand for 20 minutes. After the cells sink to the bottom, put them in the cell culture incubator on the RTCA analyzer and monitor them in real time for 72 hours.

[0113] The results are as follows Figure 5 As shown, when the cell number is 30,000 cells / well, the cells can quickly enter the logarithmic growth phase and the cell index will not decrease within 48 hours. Therefore, cell death caused by malnutrition due to excessive cell growth during the experiment can be avoided, and the time required for the entire experimental process can be met.

[0114] 2) Detection of STX and its homologues, TTX, and μ-conotoxin: Take out the cells in the logarithmic growth phase, and obtain suspended cells according to the above-mentioned step 1) of "Optimization of CCK-8 Method Conditions". After counting with a cell counting plate, adjust the cell suspension density to 3×10 5 cell / mL, inoculated on E-plate 16 at 100μL / well, let stand for 20min, and after the cells sink to the bottom, put them in the cell culture incubator on the RTCA analyzer and monitor in real time for 12h. After 12h, take out E-plate 16, discard the old culture medium, add different concentrations of STX, neoSTX, GTX1&4, TTX or μ-conotoxin mixed with 500μM Ouabain and 50μM Veratridine serum-free culture medium solution to the cells, put them back in the incubator on the RTCA analyzer, and monitor in real time for 48h. The results are as follows Figure 6-Figure 9 shown.

[0115] According to the experimental results, the detection limit of STX by the method of the present invention is 0.1ng, EC 50 =0.9392ng / mL, R 2 =0.9715; the detection limit for neoSTX is 0.1ng, EC 50 =1.004ng / mL, R 2 =0.8363; the detection limit for GTX1&4 is 0.1ng, EC 50 =3.573ng / mL, R 2 =0.9832; the detection limit for TTX is 0.1ng, EC 50 =0.03982ng / mL, R 2 =0.9197.

[0116] This example combines cell impedance technology with in vitro cytotoxicity experiments to construct a real-time, non-destructive, and highly sensitive detection system for Na + Channel mechanism of action of marine biotoxins cytotoxicity method. Cell impedance is directly converted into cell index and displayed on the display. There is little intervention during the experiment, and the chip sensor of cell adhesion is very sensitive. The LOD of STX, neoSTX, GTX1&4, TTX, and μ-CNTX GⅢA can reach 0.1ng / mL.

[0117] Example 2: Application of RTCA method

[0118] 1. Reagents, materials and instruments

[0119] Saxitoxin (STX) was purchased from Tianjin Alta Technology Co., Ltd.; Tetrodotoxin (TTX) was purchased from Beijing Dingfang Biotechnology Co., Ltd.; Ouabain and Veratridine were purchased from Selleck Biotechnology Co., Ltd., USA.

[0120]

[0121]

[0122] All of the above were synthesized by Shanghai Sangon Biotechnology Co., Ltd. Scallops and mussels were purchased from Beijing Hema Fresh. Mouse brain neuroma cells (Neuro-2a) were retained in the laboratory. 1640 culture medium, fetal bovine serum (Fetal Bovine Serum, FBS), 0.25% trypsin (containing 0.02% EDTA) were purchased from Gibco, USA; penicillin-streptomycin mixed solution was purchased from Gibco, USA. Cell culture flasks and 96-well plates were purchased from Corning, USA; E-plate 16 was purchased from Agilent Technologies. Cell counting plate was purchased from Shanghai Qiujing Biochemical Reagent Instrument Co., Ltd.; liquid nitrogen and carbon dioxide were purchased from Beijing Huanyu Jinghui Jingcheng Gas Technology Co., Ltd.

[0123] The main instruments and equipment are the same as those in Example 1.

[0124] 2. Experimental Methods

[0125] (1) Preparation of shellfish extract

[0126] Using sterile deionized water as solvent, dilute 1 mL of 38% HCl solution to 0.1 mol / L HCl solution.

[0127] Take 10 g of homogenized shellfish meat, add 70 mL of 0.1 mol / L HCl solution, boil and stir for 5 min, centrifuge at 6000 rpm / min for 10 min at 4 °C, filter with a 0.22 μm microporous filter membrane in a clean bench, collect the extract, and store it at -20 °C.

[0128] (2) Solution preparation

[0129] Using sterile deionized water as solvent, the aptamers M-30f, STX-41, STX-apt1, and STX-apt2 powders were dissolved to prepare a stock solution with a concentration of 100 μM, which was stored at -20°C after aliquoting. The above four aptamers were diluted to a concentration of 400 nM with PBS, heated at 95°C for 5 min, and placed on ice for 10 min for use. The STX mother solution was diluted to a concentration of 400 ng / mL with serum-free medium, and the diluted STX solution was mixed with the diluted 4 aptamer solutions in equal volumes and incubated at room temperature for 40 min. The Veratridine mother solution was diluted to a concentration of 200 μM and the Ouabain mother solution was diluted to a concentration of 2000 μM with serum-free 1640 medium, and the mixed solution of each aptamer and STX was mixed with the diluted Veratridine and Ouabain solutions in a volume ratio of 2:1:1 for use.

[0130] Using sterile deionized water as solvent, the aptamers DA-01, TTX-27, and TTX-07 powders were dissolved to prepare a stock solution with a concentration of 100 μM, which was stored at -20°C after aliquoting. The above three aptamers were diluted to a concentration of 400 nM with PBS, heated at 95°C for 5 min, and ice-bathed for 10 min for use. The TTX mother solution was diluted to a concentration of 400 ng / mL with serum-free medium, and the diluted TTX solution was mixed with the diluted three aptamer solutions in equal volumes and incubated at room temperature for 40 min. The Veratridine mother solution was diluted to a concentration of 200 μM and the Ouabain mother solution was diluted to a concentration of 2000 μM with serum-free medium. The mixed solution of each aptamer and TTX was mixed with the diluted Veratridine and Ouabain solutions in a volume ratio of 2:1:1 for use.

[0131] The concentration of saxitoxin (STX) standard solution was 22.332 μg / mL and stored at 4°C. The stock solution was diluted stepwise with serum-free medium to obtain standard working solutions with concentrations of 0.1 ng / mL, 0.3 ng / mL, 1 ng / mL, 3 ng / mL, 10 ng / mL, and 100 ng / mL. The Veratridine stock solution was diluted to a concentration of 150 μM and the Ouabain stock solution was diluted to a concentration of 1500 μM with serum-free medium. The stepwise diluted STX solution was mixed with the diluted Veratridine and Ouabain solutions in a volume ratio of 1:1:1 for standby use, and the diluted Ouabain and Veratridine solutions were mixed with serum-free 1640 medium in a volume ratio of 1:1:1 to obtain the OV working solution. The shellfish extract was prepared into a shellfish extract mixture containing 1 ng / mL STX and OV and an OV shellfish extract mixture without STX, and the shellfish extract was finally diluted 10 times.

[0132] (3) RTCA method to detect whether STX, TTX and corresponding aptamers bind

[0133] 1) Affinity of STX with M-30f, STX-41, STX-apt1, and STX-apt2: Cells in the logarithmic growth phase were taken out and cell suspension was prepared. After counting with a cell counting plate, the density of the cell suspension was adjusted to 3×10 5 cell / mL, seed E-plate 16 at 100μL / well, let stand for 20min, and after the cells sink to the bottom, place them in the cell culture incubator on the RTCA analyzer for real-time monitoring for 12h. After 12h, take out E-plate 16, discard the old culture medium, add the aptamers M-30f, STX-41, STX-apt1, STX-apt2 and the mixed serum-free culture medium solution of STX, Veratridine, and Ouabain to the cells, put them back in the incubator on the RTCA analyzer, and monitor them in real time for 48h.

[0134] 2) Affinity of TTX with DA-01, TTX-27, and TTX-07: Seed the plate according to step 1, and after real-time monitoring for 12 hours, take out E-plate 16, discard the old culture medium, add the mixed serum-free culture medium solution of aptamers DA-01, TTX-27, and TTX-07 and TTX, Veratridine, and Ouabain to the cells, respectively, put them back into the incubator on the RTCA analyzer, and monitor in real time for 48 hours.

[0135] Aptamers are sequences that are complementary to toxin bases. After binding to toxins, they can prevent toxins from binding to channel proteins, resulting in a weakening of the toxin's effect on cells. Fig.10As shown. The aptamers M-30f, STX-41, STX-apt1, STX-apt2 of STX and DA-01, TTX-27, TTX-07 of TTX can bind to the corresponding toxins and affect the effect of the toxins on cells. After the aptamers bind to the toxins, the relative cell viability is closer to that of the single addition of Veratridine and Ouabain, and the affinity between the aptamers and the toxins is greater. Fig.10 It can be seen that the affinity size is: M-30f>STX-apt2>STX-41>STX-apt1; DA-01>TTX-27>TTX-07.

[0136] Example 3: RTCA method for detecting Na in real samples + Inhibition of marine toxins

[0137] (1) Preparation of standard curve: Take out cells in the logarithmic growth phase, prepare cell suspension, count them with a cell counting plate, and adjust the cell suspension density to 3×10 5 cell / mL, seed E-plate 16 at 100μL / well, let stand for 20min, and after the cells sink to the bottom, place them in the cell culture incubator on the RTCA analyzer for real-time monitoring for 12h. After 12h, take out E-plate 16, discard the old culture medium, add different concentrations of STX and a mixed serum-free culture medium solution of 500μM Ouabain and 50μM Veratridine to the cells, place them back in the incubator on the RTCA analyzer, and monitor them in real time for 24h.

[0138] (2) Detection of PSP in shellfish: Take out cells in the logarithmic growth phase, prepare a cell suspension, count the cells using a cell counting plate, and adjust the cell suspension density to 3×10 5 cell / mL, seed E-plate 16 at 100 μL / well, let stand for 20 minutes, and after the cells sink to the bottom, place them in the cell culture incubator on the RTCA analyzer for real-time monitoring for 12 hours. After 12 hours, take out the E-plate 16, discard the old culture medium, add 100 μL / well working solution to the cells, and respectively prepare 2 wells of the control group (serum-free 1640 culture medium), 2 wells of the solvent control group (OV), 2 wells of the matrix spike group (serum-free 1640 solution containing 1 ng / mL STX, OV, and shellfish extract, the preparation method is the same as in Example 2), and 2 wells of the blank matrix group (serum-free 1640 solution mixed with OV and shellfish extract without STX), put them back on the RTCA analyzer in the incubator, and monitor them in real time for 24 hours.

[0139] Calculation method of PSP in extract:

[0140] Wherein, X represents the PSP content (μg / kg); ρ represents the concentration obtained according to the standard curve (μg / mL); V represents the volume of the extract (mL); f represents the dilution factor; and m represents the mass of shellfish meat (g).

[0141] The results of RTCA testing of real samples are as follows Fig.11 As shown in the figure, the dose-effect curve R 2 =0.9522,EC 50 =1.055ng / mL, which is consistent with the previous STX detection results. As shown in Figure E, the PSP content in scallops is relatively high. The relative cell viability detected by scallop matrix and scallop matrix spike is interpolated into the standard curve, and the STX equivalent in scallop matrix is ​​0.57ng / mL, which is equivalent to 39.62μg / kg of toxin in shellfish meat. The STX equivalent calculated by the scallop matrix spike result is 1.54ng / mL.

[0142] In this study, the RTCA method was applied to the affinity evaluation of nucleic acid aptamers with STX and TTX, which can provide a simple method for in vitro screening of biotoxin inhibitors. The established RTCA method has been successfully applied to the determination of Na + Detection application of channel-inhibiting biotoxins.

[0143] In view of the targets and characteristics of biological toxins in the mechanism of ion channel action, we have constructed key biosensor technologies based on ion channels, focusing on the construction of real-time label-free cell analysis technology. Through robust and sensitive cell lines, combined with ion channel inhibitors, and through combinatorial optimization, we have achieved sensitive and specific detection of ion channel inhibitory biological toxins, and developed detection kits for supporting analytical instruments. Based on the above research, we have finally achieved the establishment of an in vitro determination method for biological toxins based on the mode of toxic action, which can provide new ideas and references for the detection of other targets.

[0144] Although the specific embodiments of the present invention have been described in detail, it will be understood by those skilled in the art that various modifications and substitutions may be made to those details based on all the teachings disclosed, and these changes are within the scope of protection of the present invention. The full scope of the present invention is given by the attached claims and any equivalents thereof.

Claims

1. A method for quantitatively detecting biotoxins in a sample, comprising: (1) respectively mixing the standard of the biotoxin and the + The substance in the channel contacts the target cells, the cell index of the target cells is monitored by RTCA (real-time label-free cell analysis), the cell index is normalized, the cell viability is calculated according to the normalized cell index of the test group and the blank control group, and the functional relationship between the concentration of the biotoxin and the cell viability of the target cells is determined; (2) mixing the sample with a + The material in the channel contacts the target cells, the cell index of the target cells is monitored by RTCA, the cell index is normalized, the cell viability is calculated based on the normalized cell index of the test group and the blank control group, and the concentration of the biotoxin in the sample is calculated based on the functional relationship between the concentration of the biotoxin determined in step (1) and the cell viability of the target cells.

2. The method of claim 1, wherein: The sample contains or is suspected of containing the biotoxin; Preferably, the sample is from marine organisms, such as seaweed, shellfish or fish, such as filter-feeding shellfish (oysters, clams, scallops or mussels); Preferably, the biotoxin acts on ion channels, such as Na + Channel, K + Channels or Ca 2+ channel, preferably acting on Na + aisle; Preferably, the biotoxin is a marine biotoxin, such as paralytic shellfish poison or tetrodotoxin; Preferably, the biological toxin is selected from polypeptide toxins (e.g., conotoxins (e.g., μ-conotoxin GⅢA)); alkaloid toxins (e.g., saxitoxin (STX), neoSxitoxin (neoSTX), gonyatoxin (GTX, such as GTX1, GTX4), tetrodotoxin (TTX)); polyether toxins (e.g., ciguatoxin (CTX), breve toxin).

3. The method of claim 1 or 2, wherein the Na + The substance of the channel is selected from ouabain and / or verrucidine; Preferably, the concentration of ouabain is 300-500 μM; and / or the concentration of verrucidine is 30-50 μM; Preferably, the step (1) and step (2) are capable of activating Na + The substance of the channel is the same, and further preferably, the substance capable of activating Na + The concentration of the substances in the channels is the same.

4. The method according to any one of claims 1 to 3, wherein the concentration of the target cells is 1×10 4 / mL~5×10 5 Pieces / mL, for example 1×10 5 / mL~3×10 5 Preferably, when monitored by RTCA, the concentration of the target cells is 1×10 3 pcs / hole~5×10 4 Pieces / hole, for example 1×10 4 pcs / hole~3×10 4 Pieces / hole; Preferably, the target cell is Neuro-2a cell.

5. The method according to any one of claims 1 to 4, wherein RTCA is used for monitoring for 12 h to 72 h, such as 24 h to 72 h, 48 h to 72 h.

6. The method according to any one of claims 1 to 5, wherein the detection limit of STX is 0.1 ng; Preferably, the detection limit for neoSTX is 0.1 ng; Preferably, the detection limit for GTX, such as GTX1 and GTX4, is 0.1 ng; Preferably, the detection limit for TTX is 0.1 ng.

7. A biotoxin detection kit, comprising target cells, a biotoxin standard and a + Channel material.

8. The kit of claim 7, wherein the biotoxin acts on an ion channel, such as Na + Ion channels, K + Ion channels or Ca 2+ Ion channels, preferably Na + Ion channels; Preferably, the biotoxin is a marine biotoxin, such as paralytic shellfish poison or tetrodotoxin; Preferably, the biological toxin is selected from polypeptide toxins (e.g., tetrodotoxin (TTX), conotoxins (e.g., μ-conotoxin)); alkaloid toxins (e.g., saxitoxin (STX), neoSxitoxin (neoSTX), gonyatoxin (GTX, e.g., GTX1, GTX4), sea anemone toxin); polyether toxins (e.g., ciguatoxin (CTX), breve toxin).

9. The kit according to claim 7 or 8, wherein the target cells are Neuro-2a cells.

10. The kit according to any one of claims 7 to 9, wherein the + The substance of the channel is selected from ouabain and / or verrucidine; Preferably, the concentration of ouabain is 300-500 μM; and / or the concentration of verrudin is 30-50 μM.

11. The kit according to any one of claims 7 to 10, which is used for RTCA analysis; Preferably, the kit is used to detect biotoxins in a sample; Preferably, the sample contains or is suspected of containing the biotoxin; Preferably, the sample is from marine organisms, such as seaweed, shellfish or fish, such as filter-feeding shellfish (oysters, clams, scallops or mussels).

12. A method for screening a biotoxin inhibitor, comprising: (1) the biotoxin, the candidate agent and the + A mixed solution of the substances in the channel is added to a culture medium containing target cells, and monitored by RTCA to obtain a cell index curve of the target cells; (2) using the culture medium without the addition of the biotoxin and the candidate agent as a control to obtain a cell index curve of the control group; (3) The cell index was normalized to obtain the normalized cell index value, and the cell viability was calculated; (4) Comparing the cell viability of the test group and the control group, the closer the two are, the stronger the activity of the candidate agent in inhibiting the biological toxin.

13. The method of claim 12, wherein the biotoxin acts on an ion channel, such as Na + Channel, K + Channels or Ca 2+ channel, preferably acting on Na + aisle; Preferably, the biotoxin is a marine biotoxin, such as paralytic shellfish poison or tetrodotoxin; Preferably, the biotoxin is selected from polypeptide toxins (e.g., tetrodotoxin (TTX), conotoxins (e.g., μ-conotoxin)); alkaloid toxins (e.g., saxitoxin (STX), neoSTX, gonyatoxin (GTX, e.g., GTX1, GTX4), sea anemone toxin); polyether toxins (e.g., ciguatoxin (CTX), breve toxin); Preferably, the final concentration of the biotoxin in step (1) is 0.1 ng / mL-1 μg / mL, such as 50 ng / mL-500 ng / mL, 100 ng / mL-200 ng / mL.

14. The method of claim 12 or 13, wherein the + The substance of the channel is selected from ouabain and / or verrucidine; Preferably, in step (1), the final concentration of ouabain is 300-500 μM; and / or the final concentration of verrucidine is 30-50 μM.

15. The method according to any one of claims 12 to 14, wherein the concentration of the target cells is 1×10 4 / mL~5×10 5 Pieces / mL, for example 1×10 5 / mL~3×10 5 Preferably, when monitored by RTCA, the concentration of the target cells is 1×10 3 pcs / hole~5×10 4 Pieces / hole, for example 1×10 4 pcs / hole~3×10 4 Pieces / hole; Preferably, the target cell is Neuro-2a cell.

16. The method according to any one of claims 12 to 15, wherein the final concentration of the candidate agent is 50 nM-500 nM, such as 100 nM-200 nM.

17. The method of any one of claims 12-16, wherein RTCA is used for monitoring for 12h-72h, such as 24h-72h, 48h-72h.